Boda Z

No ORCID on file · 2 papers in corpus
nonrandomized-trial 2025
AJOG global reports ·doi:10.1016/j.xagr.2025.100501

BACKGROUND: Heavy menstrual bleeding is the dominant symptom in girls/women with von Willebrand disease (VWD), affecting ∼80 to 90%. Female patients with VWD are typically diagnosed later than males, despite the disproportionate impact of h…

lab-animal 2024
International journal of molecular sciences ·doi:10.3390/ijms25052893

Antithrombin (AT) is the major plasma inhibitor of thrombin (FIIa) and activated factor X (FXa), and antithrombin deficiency (ATD) is one of the most severe thrombophilic disorders. In this study, we identified nine novel AT mutations and i…